Friday, August 01, 2025 3:00:51 PM
Chuigray,
While I agree that this is possible, I also believe it will take several years and like DCVax-L to be most effective, other therapeutics that work with it will have to be determined, or developed.
We need to realize that the DCVax's alone are beneficial, but they're far from curative in the majority of patients. Our vaccine is building a tremendous increase in T-cells and that's something that can be built upon.
I believe the DCVax's will be a part of the long term goal of curing cancer, but it won't do it all by themselves. It will take many year to go from using DCVax-Direct on inoperable cancers to pretreating cancers before surgery, and then perhaps eliminating the surgery completely. If I make the century mark, in 18 years, perhaps I'll see it.
Gary
While I agree that this is possible, I also believe it will take several years and like DCVax-L to be most effective, other therapeutics that work with it will have to be determined, or developed.
We need to realize that the DCVax's alone are beneficial, but they're far from curative in the majority of patients. Our vaccine is building a tremendous increase in T-cells and that's something that can be built upon.
I believe the DCVax's will be a part of the long term goal of curing cancer, but it won't do it all by themselves. It will take many year to go from using DCVax-Direct on inoperable cancers to pretreating cancers before surgery, and then perhaps eliminating the surgery completely. If I make the century mark, in 18 years, perhaps I'll see it.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
